US United States English
US Estados Unidos Español
PL Polska Polski
ZA South Africa English
ZA Suid-Afrika Afrikaans
United States English

Clinical Research Studies

The BTKi-SLE Study is a Phase 2 clinical research study.

Before an investigational medication, device or procedure is approved for general use, it must be shown to be both well-tolerated and effective.

This is accomplished through clinical research studies, also called clinical trials. Clinical research studies are carefully designed and monitored research studies intended to test and evaluate these investigational medications, devices or procedures. They answer important questions, such as:

Clinical research studies are regulated by government agencies to ensure the highest standards are being met. All potential new medications must be tested in a series of clinical research studies before they can be prescribed by doctors.

Why do people participate in clinical research studies?

People who participate in clinical research studies volunteer for many reasons. Some of these are:

Receive study-related medical tests and procedures at no cost
Receive careful monitoring from medical staff throughout the study
Potentially receive the investigational medication
Contribute to medical science and advance potential treatments to help people manage their conditions now and in the future
Learn more about their condition and how it is managed

What are the different phases of clinical research studies (also known as clinical trials)?

Clinical research studies are divided into different phases. Each phase is designed to collect specific information about the investigational medication or treatment.

Phase 1 studies

The first human tests of investigational medications or treatments are in Phase 1 studies. Phase 1 studies are designed to determine the most appropriate dose of the investigational medication and to check for any potential side effects. These studies usually involve a small number of participants. Because Phase 1 studies use investigational medications that have never been tested in humans, they may involve significant risks.

Phase 2 studies

Phase 2 studies test the investigational medication in a larger group of patients to evaluate the effectiveness of the medication on the disease being studied and to confirm the safety data established in the Phase 1 study.

  • Many Phase 2 studies compare the investigational medication to a placebo (inactive medication) or an existing standard treatment. For clinical trials involving a placebo, participants have a chance to receive the investigational medication but also have a chance to receive the inactive medication.
  • As with every other study, patients in Phase 2 studies are closely monitored by the study team throughout their participation in the study.

Phase 3 studies (for medication approval)

In Phase 3 clinical research studies, basic information is known about the investigational medication from results collected in earlier studies. Phase 3 studies test the safety and how well the investigational medication works in hundreds or even thousands of participants. Phase 3 studies also often compare the investigational medication to a placebo (inactive medication) or an existing standard treatment.

Phase 4 studies (once the medication is approved)

These clinical research studies are conducted after the regulatory authorities have approved a medication and it is available for use by the general public. Phase 4 trials may evaluate the long-term safety of the approved medication.

Learn more about the BTKi-SLE Study